Correlation Between In8bio and Icosavax
Can any of the company-specific risk be diversified away by investing in both In8bio and Icosavax at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining In8bio and Icosavax into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between In8bio Inc and Icosavax, you can compare the effects of market volatilities on In8bio and Icosavax and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in In8bio with a short position of Icosavax. Check out your portfolio center. Please also check ongoing floating volatility patterns of In8bio and Icosavax.
Diversification Opportunities for In8bio and Icosavax
Excellent diversification
The 3 months correlation between In8bio and Icosavax is -0.58. Overlapping area represents the amount of risk that can be diversified away by holding In8bio Inc and Icosavax in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Icosavax and In8bio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on In8bio Inc are associated (or correlated) with Icosavax. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Icosavax has no effect on the direction of In8bio i.e., In8bio and Icosavax go up and down completely randomly.
Pair Corralation between In8bio and Icosavax
Given the investment horizon of 90 days In8bio is expected to generate 8.52 times less return on investment than Icosavax. In addition to that, In8bio is 1.94 times more volatile than Icosavax. It trades about 0.0 of its total potential returns per unit of risk. Icosavax is currently generating about 0.04 per unit of volatility. If you would invest 850.00 in Icosavax on August 31, 2024 and sell it today you would earn a total of 52.00 from holding Icosavax or generate 6.12% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 28.51% |
| Values | Daily Returns |
In8bio Inc vs. Icosavax
Performance |
| Timeline |
| In8bio Inc |
| Icosavax |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
In8bio and Icosavax Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with In8bio and Icosavax
The main advantage of trading using opposite In8bio and Icosavax positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if In8bio position performs unexpectedly, Icosavax can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Icosavax will offset losses from the drop in Icosavax's long position.| In8bio vs. Cue Biopharma | In8bio vs. Eliem Therapeutics | In8bio vs. Inhibrx | In8bio vs. Molecular Partners AG |
| Icosavax vs. Terns Pharmaceuticals | Icosavax vs. Amylyx Pharmaceuticals | Icosavax vs. Acumen Pharmaceuticals | Icosavax vs. Inozyme Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Other Complementary Tools
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Fundamental Analysis View fundamental data based on most recent published financial statements |